
AbCellera Biologics ABCL
$ 3.4
-3.68%
Annual report 2025
added 02-24-2026
AbCellera Biologics Total Inventories 2011-2026 | ABCL
Annual Total Inventories AbCellera Biologics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.34 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.34 M | 6.34 M | 6.34 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Autolus Therapeutics plc
AUTL
|
4.14 M | $ 1.37 | -4.2 % | $ 350 M | ||
|
Axsome Therapeutics
AXSM
|
27.9 M | $ 156.92 | -1.23 % | $ 7.81 B | ||
|
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | ||
|
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B | ||
|
BioMarin Pharmaceutical
BMRN
|
1.3 B | $ 54.13 | -1.64 % | $ 10.4 B | ||
|
Cara Therapeutics
CARA
|
2.82 M | - | -3.03 % | $ 260 M | ||
|
ChemoCentryx
CCXI
|
851 K | - | - | $ 3.74 B | ||
|
Coherus BioSciences
CHRS
|
3.17 M | $ 1.52 | -5.59 % | $ 178 M | ||
|
Clovis Oncology
CLVS
|
13.7 M | - | -7.23 % | $ 13 M |